878 filings
Page 20 of 44
424B5
s6nw6p3561t75
31 Oct 13
Prospectus supplement for primary offering
12:00am
424B5
rlx3jr9v4q213bee4i
30 Oct 13
Prospectus supplement for primary offering
12:00am
8-K/A
hzv4wlco0mf73me
25 Oct 13
Entry into a Material Definitive Agreement
12:00am
8-K
62865y ufai7kcc
17 Oct 13
Regulation FD Disclosure
12:00am
8-K
ajclf 3cjgzqq2qpl9
4 Oct 13
Discovery Labs Announces FDA Approval of SURFAXIN® (lucinactant) Updated Product Specifications
12:00am
S-8
p36fwp0ycc112om w8rs
1 Oct 13
Registration of securities for employees
12:00am
D
sfxf44ix2nd
12 Sep 13
$58.1K in equity, sold $14.53K, 1 investor
12:00am
CT ORDER
ajwtm
3 Sep 13
Confidential treatment order
12:00am
8-K
n5r5bednmb0
8 Aug 13
Discovery Labs Reports Second Quarter 2013 Financial Results
12:00am
S-8
ojc03qw1k p8js04
15 Jul 13
Registration of securities for employees
12:00am
EFFECT
rb9lvu0
20 Jun 13
Notice of effectiveness
12:00am
CORRESP
8zrpgk1ns89kuoim
19 Jun 13
Correspondence with SEC
12:00am
CT ORDER
k4kyr72h0mue
18 Jun 13
Confidential treatment order
12:00am
CORRESP
ee9kkaqr tnodvfj6
14 Jun 13
Correspondence with SEC
12:00am
8-K/A
zzsf 8pmjk
14 Jun 13
Financial Statements and Exhibits
12:00am
8-K
n7stsq9vi
11 Jun 13
Amendments to Articles of Incorporation or Bylaws
12:00am
8-K
wyup215 n95vpteeix
10 Jun 13
Discovery Labs Responds to FDA Request for Clarification of Recently
12:00am
D
vah83b6lk2ichf64k
7 Jun 13
$12K in equity, sold $12K, 1 investor
12:00am
8-K
2rkiyqi4c
31 May 13
Other Events
12:00am